NPD-0414-2 and NPD-0414-24, Two Chemical Entities Designed as Aryl Hydrocarbon Receptor (AhR) Ligands, Inhibit Gut Inflammatory Signals.

导出 LinkOut

翻译打印收藏纠错

作者： Irene,Marafini ^[1] ; Davide,Di Fusco ^[1] ; Vincenzo,Dinallo ^[1] ; Eleonora,Franzè ^[1] ; Carmine,Stolfi ^[1] ; Giuseppe,Sica ^[2] ; Giovanni,Monteleone ^[1] ; Ivan,Monteleone ^[3]

作者单位： Department of Systems Medicine, Gastroenterology, University of Tor Vergata, Rome, Italy. ^[1] Department of Surgery, University of Tor Vergata, Rome, Italy. ^[2] Department of Biomedicine and Prevention, University of Tor Vergata, Rome, Italy. ^[3]

关键词 AhR Crohn’s disease Ficz IBD IFN-γ Il-22 TNBS ulcerative colitis

DOI 10.3389/fphar.2019.00380

PMID 31031628

发布时间 2020-10-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交

浏览6

Frontiers in pharmacology

2019年10卷

380页

相似文献

中文期刊
外文期刊
学位论文
会议论文

检索历史清除

NPD-0414-2 and NPD-0414-24, Two Chemical Entities Designed as Aryl Hydrocarbon Receptor (AhR) Ligands, Inhibit Gut Inflammatory Signals.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

参考文献：
指定格式：	NoteExpress EndNote RefWorks NoteFirst

检索历史 清除

NPD-0414-2 and NPD-0414-24, Two Chemical Entities Designed as Aryl Hydrocarbon Receptor (AhR) Ligands, Inhibit Gut Inflammatory Signals.

Frontiers in pharmacology

相似文献

Frontiers in pharmacology

相关期刊

检索历史清除